Medtronic Company Profile (NYSE:MDT)

Analyst Ratings

Consensus Ratings for Medtronic (NYSE:MDT) (?)
Ratings Breakdown: 5 Hold Rating(s), 18 Buy Rating(s)
Consensus Rating:Buy (Score: 2.78)
Consensus Price Target: $88.08 (0.19% downside)

Analysts' Ratings History for Medtronic (NYSE:MDT)
Show:
DateFirmActionRatingPrice TargetActions
7/6/2016Goldman Sachs Group Inc.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/28/2016Credit Suisse Group AGReiterated RatingBuy$85.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/27/2016Evercore ISIReiterated RatingBuy$86.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/27/2016Needham & Company LLCReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/27/2016BTIG ResearchReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/20/2016ArgusReiterated RatingHold -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/15/2016Piper Jaffray Cos.Reiterated RatingOverweight$93.00 -> $94.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/15/2016Deutsche Bank AGReiterated RatingBuy$90.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/13/2016SunTrust Banks Inc.Boost Price TargetBuy$93.00 -> $98.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/8/2016GuggenheimInitiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/7/2016Wells Fargo & Co.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/7/2016Oppenheimer Holdings Inc.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/7/2016Morgan StanleyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/7/2016BMO Capital MarketsReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/4/2016Bank of America Corp.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/2/2016WedbushReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2016Leerink SwannReiterated RatingHold$82.00 -> $85.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2016Royal Bank Of CanadaReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2016Jefferies GroupReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/17/2016Nomura Holdings Inc.Initiated CoverageBuy$86.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/2/2016JPMorgan Chase & Co.Lower Price TargetOverweight$88.00 -> $85.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/4/2015William BlairReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/2/2015Cowen and CompanyReiterated RatingOutperform$88.00 -> $90.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/25/2015Sterne Agee CRTReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/4/2015S&P Equity ResearchReiterated RatingBuy$89.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/18/2015ScotiabankReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/18/2014Citigroup Inc.Reiterated RatingBuy$69.00 -> $71.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/27/2014 forward)

Earnings

Earnings History for Medtronic (NYSE:MDT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/25/2016        
5/31/2016Q416$1.26$1.27$7.49 billion$7.57 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/1/2016Q316$1.06$1.06$6.99 billion$6.93 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
12/3/2015Q216$1.00$1.03$7.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
9/3/2015Q116$1.01$1.02$7.30 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
6/2/2015Q415$1.11$1.16$7.18 billion$7.30 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/17/2015Q3$0.97$1.04$4.25 million$4.32 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/18/2014Q2$0.96$0.96$4.37 million$4.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/19/2014Q115$0.92$0.93$4.25 billion$4.27 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/20/2014Q414$1.12$1.12$4.58 billion$4.60 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/18/2014Q314$0.91$0.91$4.15 billion$4.20 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/19/2013Q214$0.90$0.91$4.18 billion$4.20 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/20/2013Q1 2014$0.88$0.88$4.11 billion$4.10 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/21/2013Q4 2013$1.03$1.10$4.39 billion$4.50 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/19/2013Q3 2013$0.91$0.93$4.03 billion$4.03 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/20/20120.88$0.88$4.10 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/21/2012$0.85$0.85ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/22/2012$0.98$0.99ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/21/2012$0.84$0.88ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/22/2011$0.82$0.84ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/23/2011$0.79$0.79ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/24/2011$0.93$0.90ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/22/2011$0.84$0.86ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Medtronic (NYSE:MDT)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163$1.05$1.07$1.06
Q2 201610$1.24$1.29$1.26
Q3 20167$1.05$1.15$1.09
Q4 20169$1.11$1.27$1.17
Q1 20177$1.00$1.15$1.03
Q2 20178$1.12$1.38$1.23
Q3 20177$1.14$1.25$1.17
Q4 20177$1.29$1.39$1.34
Q1 20183$1.08$1.27$1.18
Q2 20182$1.20$1.32$1.26
Q3 20182$1.25$1.30$1.28
Q4 20182$1.41$1.55$1.48
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for Medtronic (NYSE:MDT)
Annual Dividend:$1.72
Dividend Yield:1.95%
Payout Ratio:69.35% (Based on Trailing 12 Months of Earnings)
36.91% (Based on Current Year Consensus EPS Estimate)
33.27% (Based on Next Year Consensus EPS Estimate)
Dividend Growth:2.70% (3 Year Average)

Dividend History for Medtronic (NYSE:MDT)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
6/24/2016quarterly$0.431.85%7/6/20167/8/20167/27/2016Tweet This Announcement  Share This Announcement on StockTwits
2/22/2016quarterly$0.381.98%3/22/20163/24/20164/15/2016Tweet This Announcement  Share This Announcement on StockTwits
12/11/2015quarterly$0.381.96%12/22/201512/24/20151/15/2016Tweet This Announcement  Share This Announcement on StockTwits
8/21/2015quarterly$0.382.18%9/23/20159/25/201510/16/2015Tweet This Announcement  Share This Announcement on StockTwits
6/19/2015quarterly$0.381.97%6/25/20156/29/20157/17/2015Tweet This Announcement  Share This Announcement on StockTwits
2/20/2015quarterly$0.311.55%3/26/20153/30/20154/17/2015Tweet This Announcement  Share This Announcement on StockTwits
12/4/2014$0.3112/30/20141/2/20151/16/2015Tweet This Announcement  Share This Announcement on StockTwits
12/5/2014quarterly$0.311.63%12/30/20141/2/20151/6/2015Tweet This Announcement  Share This Announcement on StockTwits
8/21/2014quarterly$0.311.92%10/1/201410/3/201410/24/2014Tweet This Announcement  Share This Announcement on StockTwits
6/16/2014quarterly$0.311.98%7/1/20147/3/20147/25/2014Tweet This Announcement  Share This Announcement on StockTwits
2/14/2014quarterly$0.281.97%4/2/20144/4/20144/25/2014Tweet This Announcement  Share This Announcement on StockTwits
12/5/2013quarterly$0.281.93%12/31/20131/3/20141/24/2014Tweet This Announcement  Share This Announcement on StockTwits
8/22/2013quarterly$0.282.12%10/2/201310/4/201310/25/2013Tweet This Announcement  Share This Announcement on StockTwits
6/21/2013quarterly$0.282.13%7/2/20137/5/20137/26/2013Tweet This Announcement  Share This Announcement on StockTwits
2/15/2013quarterly$0.262.21%4/3/20134/5/20134/26/2013Tweet This Announcement  Share This Announcement on StockTwits
12/9/2012quarterly$0.262.44%12/13/201212/17/201212/28/2012Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Medtronic (NYSE:MDT)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
7/15/2016Geoffrey MarthaEVPSell3,766$88.26$332,387.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/13/2016Gary Lee EllisEVPSell35,495$88.64$3,146,276.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/13/2016Shirley A JacksonDirectorSell2,104$88.64$186,498.56View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/6/2016Carol A. SurfaceSVPSell9,787$87.08$852,251.96View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/5/2016Bryan C. HansonEVPSell15,272$87.11$1,330,343.92View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2016Richard KuntzVPSell49,905$82.60$4,122,153.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/1/2016Richard KuntzVPSell4,000$75.22$300,880.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/18/2016Shirley A JacksonDirectorSell1,238$75.60$93,592.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/17/2016Omar IshrakCEOSell23,799$76.15$1,812,293.85View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/4/2016Bryan C HansonEVPSell5,000$75.00$375,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/5/2016Bryan C. HansonEVPSell5,000$76.14$380,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/8/2016Bryan C HansonEVPSell5,000$75.00$375,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/4/2015Richard KuntzVPSell13,715$78.06$1,070,592.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/15/2015Omar IshrakCEOSell20,000$69.43$1,388,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/14/2015Carol A SurfaceSVPSell13,722$75.83$1,040,539.26View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/6/2015Richard KuntzVPSell31,768$77.39$2,458,525.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/25/2015Gary Lee EllisCFOSell43,183$77.81$3,360,069.23View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/13/2015Omar IshrakCEOSell20,000$76.24$1,524,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/19/2015Christopher J OconnellEVPSell50,361$78.22$3,939,237.42View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/19/2014Richard KuntzVPSell12,855$74.54$958,211.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/2/2014Shirley A JacksonDirectorSell1,102$74.43$82,021.86View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/28/2014Christopher J OconnellEVPSell42,921$73.95$3,174,007.95View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/6/2014Christopher J OconnellEVPSell15,388$64.98$999,912.24View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/26/2014Christopher J OconnellEVPSell28,000$63.57$1,779,960.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/26/2014Shirley A JacksonDirectorSell2,769$63.66$176,274.54View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/17/2014Catherine SzymanVPSell29,420$58.79$1,729,601.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/9/2014Richard KuntzVPSell2,512$60.98$153,181.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/1/2014Gary Lee EllisCFOSell4,246$61.48$261,044.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/28/2014Christopher OconnellEVPSell1,982$60.39$119,692.98View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/20/2014Catherine SzymanVPSell14,979$59.57$892,299.03View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/14/2014Omar IshrakCEOSell10,000$59.12$591,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2014Neil AyotteVPSell1,845$59.64$110,035.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/4/2013Neil AyotteVPSell1,729$57.14$98,795.06View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/13/2013Omar IshrakCEOSell10,000$53.58$535,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/26/2013Catherine SzymanVPSell56,998$52.60$2,998,094.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/22/2013H James DallasVPSell32,332$53.19$1,719,739.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/21/2013H James DallasVPSell36,256$52.82$1,915,041.92View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/21/2013Shirley JacksonDirectorSell8,033$52.84$424,463.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/11/2013Christopher J OconnellEVPSell30,429$52.92$1,610,302.68View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/11/2013Gary Lee EllisCFOSell32,602$53.62$1,748,119.24View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/11/2013H James DallasVPSell69,889$53.72$3,754,437.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2013H James DallasVPSell20,579$52.10$1,072,165.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/26/2013D Cameron FindlayVPSell75,042$52.20$3,917,192.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/19/2013H James DallasVPSell94,117$52.74$4,963,730.58View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/22/2013Richard H AndersonDirectorBuy4,800$52.32$251,136.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/10/2013Jack W SchulerDirectorSell34,230$48.24$1,651,255.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Medtronic (NYSE:MDT)
DateHeadline
07/26/16 03:29 PMWhat Analysts Recommend ahead of BDX’s Fiscal 3Q16 Earnings -
07/25/16 12:00 PMETF’s with exposure to Medtronic Plc : July 25, 2016 -
07/25/16 09:39 AMMedtronic Unveils VariLoc Variable Angle Locking Technology for Treatment of Fractures
07/24/16 03:10 PMBetter Buy: TransEnterix, Inc. vs. Medtronic - See how the robotic surgery stock stacks up against the world's largest medical-device company.
07/22/16 12:28 PMSt. Jude Medical Gets ‘Hold’ Rating from 96% of Analysts -
07/22/16 08:25 AMMedtronic Plc :MDT-US: Earnings Analysis: 2016 By the Numbers : July 22, 2016 -
07/22/16 08:05 AMStock Update: Medtronic Inc (NYSE:MDT) - Medtronic Receives First-Ever FDA Clearance for Cement-Augmented ... - Jutia Group (press release) (blog)
07/22/16 08:05 AMAnalysts Observing Stocks: Medtronic plc (NYSE:MDT) , Molina Healthcare Inc (NYSE:MOH) - Street Updates
07/22/16 08:05 AMBroker Outlook For Medtronic, Inc. (NYSE:MDT) - Fiscal Standard
07/21/16 07:15 AMMedtronic gets FDA thumbs up for latest product -
07/20/16 05:49 PMInsider Activity – Medtronic plc. Ordinary Shares (NYSE:MDT)
07/20/16 05:49 PMMedtronic PLC (NYSE:MDT)’s Robotic Surgery Partner Mazor Releases Studies Advocating The Effectiveness Of Its Machine
07/20/16 05:49 PMStock Update: Medtronic Inc (NYSE:MDT) – Medtronic Receives First-Ever FDA Clearance for Cement-Augmented Pedicle Screws
07/20/16 11:17 AMMedtronic Gets First-Ever FDA Approval For Cement-Augmented Pedicle Screws -
07/20/16 08:03 AMCompany Update: Medtronic Inc (NYSE:MDT) - Medtronic Expands Continuous Glucose Monitoring (CGM) Solutions ... - Jutia Group (press release) (blog)
07/19/16 05:16 PMRail-Splitter Capital Management LLC Increased Medtronic INC Mdt (NYSE:MDT) by $3.04 Million as Shares Declined - Consumer Eagle
07/19/16 05:16 PMDividend Alert For Medtronic, Inc. (NYSE:MDT) - Stocks Daily
07/19/16 03:21 PMIntuitive Surgical Posts Q2 EPS, Sales Beat As Da Vinci Sales Rise -
07/19/16 11:12 AMNuVasive (NUVA) Enters Settlement, Patent License Agreement with Medtronic (MDT)
07/19/16 08:03 AMMedtronic Expands Continuous Glucose Monitoring (CGM) Solutions for People with Diabetes Using Insulin Injections with CE Mark Receipt - [GlobeNewswire] - New Guardian (TM) Connect System Will Be Launched in Q2 FY17 Outside the U.S. DUBLIN - July 19, 2016 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received ...
07/18/16 05:15 PMNext Weeks Broker Price Targets For Medtronic, Inc. (NYSE:MDT) - Fiscal Standard
07/18/16 05:15 PMMedtronic, Inc. (NYSE:MDT) Earnings Concentration and Analyst Target Watch - Engelwood Daily
07/18/16 05:15 PMNew High Healthcare Stocks- Pfizer Inc. (NYSE:PFE), Medtronic plc (NYSE:MDT) - Seneca Globe
07/18/16 05:15 PMEarnings Focus and Crowd Sourced Sentiment Review for Medtronic, Inc. (NYSE:MDT) - TGP
07/18/16 11:40 AMFDA approves Medtronic product -
07/18/16 08:02 AMMedtronic Receives FDA Approval for Two-Level Prestige LP(TM) Cervical Disc Procedures - [GlobeNewswire] - Two-Level Use of Prestige LP Cervical Disc Exhibited Statistical Superiority in Overall Success at 24 Months Compared to Patients Treated with Two-Level Fusion DUBLIN - July 18, 2016 - Medtronic plc (NYSE: ...
07/16/16 08:30 AMStock Update: Medtronic Inc (NYSE:MDT) – Medtronic Launches Revamped Minimally Invasive Spine Fusion Procedures - Jutia Group (press release) (blog)
07/16/16 08:30 AMMedtronic Introduces Revamped Minimally Invasive Spine Fusion Procedures - Benzinga
07/15/16 04:12 PMMedicare Backs ID Numbers for Medical Devices
07/15/16 04:12 PMStock Update: Medtronic Inc (NYSE:MDT) – Medtronic Launches Revamped Minimally Invasive Spine Fusion Procedures
07/15/16 12:28 PMMedtronic Introduces Revamped Minimally Invasive Spine Fusion Procedures -
07/15/16 10:02 AMMedtronic Foundation Calls for Applications for 2016 Bakken Invitation Award - [GlobeNewswire] - International Award Honors the Philanthropic Power of Patients; At Least 10 Honorees Will Each Receive a $20,000 Grant Donated to an Eligible Charity Organization of Their Choice DUBLIN - July 15, 2016 ...
07/15/16 09:32 AMAnalyst Rating Trends to Observe: Medtronic plc (NYSE:MDT) , Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) - Street Updates
07/15/16 09:02 AMMedtronic Launches Revamped Minimally Invasive Spine Fusion Procedures - [GlobeNewswire] - Innovative Procedural Solutions Offer Efficiencies for Surgeons Using a Lateral Approach DUBLIN - July 15, 2016 - Medtronic plc (NYSE: MDT) today announced the continued development of the OLIF Platform ...
07/14/16 05:23 PMYesterday Stock's Price Swings: Medtronic plc (NYSE:MDT) , Amicus Therapeutics, Inc. (NASDAQ:FOLD) - Street Updates
07/13/16 05:31 PMMedtronic, Inc. (NYSE:MDT) Wall Street Analyst Recommendation Outlook - Telanagana Press
07/13/16 09:15 AMMedtronic Gets FDA Approval For IN.PACT Admiral DCB 150 mm Lengths - Medtronic plc (NYSE: MDT) disclosed that it received FDA approval for the IN.PACT Admiral drug-coated balloon (DCB) in longer, 150 mm lengths. According to the company, the new 150 mm length balloon is available in four, five, and six mm diameters. It would offer greater treatment options for long lesions in patients with peripheral artery disease (PAD). Medtronic said the IN.PACT SFA Trial, a prospective, multi-center, randomized, controlled pivotal study demonstrated, in a subgroup of patients with lesions ...Full story available on Benzinga.com
07/13/16 08:03 AMAnalyst Target and Average Rating Watch: Medtronic, Inc. (NYSE:MDT) - Press Telegraph
07/13/16 08:02 AMMedtronic Receives FDA Approval for IN.PACT Admiral DCB 150 mm Lengths - [GlobeNewswire] - Expanded Treatment Options for Patients with Longer SFA Lesions with Best-In-Class Drug-Coated Balloon Technology Now Available DUBLIN - July 13, 2016 - Medtronic plc (NYSE: MDT) has received U.S. Food ...
07/12/16 05:22 PMAnalysts Rating updates about two Stocks: Medtronic plc (NYSE:MDT) , Mast Therapeutics, Inc. (NYSEMKT:MSTX) - Street Updates
07/12/16 05:22 PMRail-Splitter Capital Management LLC Increased Medtronic INC Mdt (NYSE:MDT) by $3.04 Million as Shares Declined - Press Telegraph
07/12/16 05:22 PMMedtronic Gets FDA Approval For NuVent - Benzinga
07/12/16 05:22 PMMedtronic, Inc. (NYSE:MDT) Dividend Payout Is $0.43 - Stocks Daily
07/12/16 09:31 AMInvestor News: Investigation over Takeover of HeartWare International Inc (NASDAQ:HTWR)
07/11/16 12:55 PMMedtronic Gets FDA Approval For NuVent - Medtronic plc (NYSE: MDT) revealed the approval of Food and Drug Administration (FDA) for its NuVent, an EM sinus dilation system, for patients with scarred, granulated, or previously surgically-altered tissue - an expansion of indications. According to the company, patients coming in for revision sinus surgery (RSS) have these tissue characteristics. Medtronic said NuVent was the first and only balloon sinus dilation system ...Full story available on Benzinga.com
07/11/16 08:03 AMFDA Clears Expanded Indications for Medtronic NuVent(TM) EM Sinus Dilation System with Image Guidance - [GlobeNewswire] - Clinical Study Conducted on Revision Subjects Support Expanded Indication for Patients with Previously Surgically Altered Tissue DUBLIN - July 11, 2016 - Medtronic plc (NYSE: MDT) today announced U.S. ...
07/11/16 08:02 AM9:02 am Medtronic confirms FDA clearance & expanded indications for NuVent, an EM sinus dilation system for patients with scarred, granulated, or previously surgically-altered tissue -
07/09/16 08:28 AMPerformance Recap and Target Perspective on Medtronic, Inc. (NYSE:MDT) - Press Telegraph
07/09/16 12:05 AMA Look at Medtronic’s Revenue Growth and Future Estimates -
07/08/16 03:35 PMMedtronic: How Beacon Services Enhance Customer Value -

Social

About Medtronic

Medtronic logoMedtronic plc (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine, Neuromodulation, Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. Medtronic, Inc. is a subsidiary of the Company.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NYSE
  • Symbol: MDT
  • CUSIP: 58505510
Key Metrics:
  • Previous Close: $88.25
  • 50 Day Moving Average: $86.33
  • 200 Day Moving Average: $79.49
  • P/E Ratio: 35.58
  • P/E Growth: 2.42
  • Market Cap: $123.09B
  • Beta: 0.9
  • Current Year EPS Consensus Estimate: $4.66 EPS
  • Next Year EPS Consensus Estimate: $5.17 EPS
Additional Links:
Medtronic (NYSE:MDT) Chart for Wednesday, July, 27, 2016